These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7607956)

  • 1. Late effects of hyperfractionated-radiotherapy for head and neck cancer--in response to Drs. Withers and Taylor, IJROBP 32:887-888; 1995.
    Fu KK; Cox JD
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1266. PubMed ID: 7607956
    [No Abstract]   [Full Text] [Related]  

  • 2. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
    Fu KK; Pajak TF; Marcial VA; Ortiz HG; Rotman M; Asbell SO; Coia LR; Vora NL; Byhardt R; Rubin P
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):577-88. PubMed ID: 7790242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships for late radiation effects in the head and neck: regarding the analysis of the RTOG 8313 trial, Fu et al. IJROBP 32:577-588; 1995.
    Bentzen SM; Thames HD
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):523-5. PubMed ID: 8567362
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the editor: regarding Withers et al., IJROBP 31:353-359; 1995.
    Ben-Josef E
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1267. PubMed ID: 7607958
    [No Abstract]   [Full Text] [Related]  

  • 5. Interfraction interval and dose-response in RTOG trials--regarding Fu et al., IJROBP 32:577-588; 1995.
    Withers HR; Taylor JM
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):887-8. PubMed ID: 7790277
    [No Abstract]   [Full Text] [Related]  

  • 6. In regard to Staar et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefits of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. IJROBP 2001;50:1161-1171.
    Grabenbauer GG; Sauer R
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):300. PubMed ID: 12183004
    [No Abstract]   [Full Text] [Related]  

  • 7. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Radiation Therapy Oncology Group].
    Herrmann T
    Strahlenther Onkol; 1995 Apr; 171(4):244-5. PubMed ID: 7740414
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
    Marcu L; Bezak E
    Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy oncology: in regard to Fu et al., IJROBP 2000;48:7-16.
    Logie MB
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148. PubMed ID: 11958925
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of mucosal acute radiation injury during accelerated-hyperfractionted split course radiotherapy (CHA-CHA) in advanced head and neck neoplasms].
    Miszczyk L; Tarnawski R; Woźniak G; Maciejewski B
    Otolaryngol Pol; 2002; 56(5):543-9. PubMed ID: 12523161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hyperfractionated radiotherapy of tumors in the head-neck area].
    Dubben HH; Baumann M; Fassbender T; Beck-Bornholdt HP
    Strahlenther Onkol; 1992 Jul; 168(7):373-82. PubMed ID: 1496447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers.
    Nguyen TD; Panis X; Froissart D; Legros M; Coninx P; Loirette M
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):23-5. PubMed ID: 3335458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfractionated accelerated radiotherapy in locally advanced head and neck cancers.
    Yoney A; Akboru H; Kandemir O; Unsal M
    Onkologie; 2007 Oct; 30(10):479-84. PubMed ID: 17890886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enigma of accelerated hyperfractionated radiation therapy for head and neck cancer.
    Wang CC
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):209-10. PubMed ID: 3335455
    [No Abstract]   [Full Text] [Related]  

  • 19. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.
    Glicksman AS; Wanebo HJ; Slotman G; Liu L; Landmann C; Clark J; Zhu TC; Lohri A; Probst R
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):721-9. PubMed ID: 9336155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between normal tissue reactions and local tumour control in head and neck cancer patients treated by definitive radiotherapy: regarding IJROBP 35:455-462; 1996.
    Burnet NG; Wurm R; Nyman J; Peacock JH
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1137-8. PubMed ID: 9276382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.